| Literature DB >> 33529175 |
Swathi Karthikeyan1, Ian G Waters1, Lauren Dennison1, David Chu1, Joshua Donaldson2, Dong Ho Shin2, D Marc Rosen1, Paula I Gonzalez-Ericsson3,4, Violeta Sanchez2,4, Melinda E Sanders3,4, Morgan V Pantone2, Riley E Bergman2, Brad A Davidson2, Sarah C Reed2, Daniel J Zabransky1, Karen Cravero1, Kelly Kyker-Snowman1, Berry Button1, Hong Yuen Wong2, Paula J Hurley2, Sarah Croessmann2, Ben Ho Park1,2.
Abstract
Intratumor heterogeneity is an important mediator of poor outcomes in many cancers, including breast cancer. Genetic subclones frequently contribute to this heterogeneity; however, their growth dynamics and interactions remain poorly understood. PIK3CA and HER2 alterations are known to coexist in breast and other cancers. Herein, we present data that describe the ability of oncogenic PIK3CA mutant cells to induce the proliferation of quiescent HER2 mutant cells through a cell contact-mediated mechanism. Interestingly, the HER2 cells proliferated to become the major subclone over PIK3CA counterparts both in vitro and in vivo. Furthermore, this phenotype was observed in both hormone receptor-positive and -negative cell lines, and was dependent on the expression of fibronectin from mutant PIK3CA cells. Analysis of human tumors demonstrated similar HER2:PIK3CA clonal dynamics and fibronectin expression. Our study provides insight into nonrandom subclonal architecture of heterogenous tumors, which may aid the understanding of tumor evolution and inform future strategies for personalized medicine.Entities:
Keywords: Breast cancer; Cell Biology; Molecular biology; Molecular genetics; Oncology
Year: 2021 PMID: 33529175 PMCID: PMC7954606 DOI: 10.1172/JCI143557
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808